Thomas Grellety
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 5
-
- Advanced Breast Cancer Therapies 7
- Sarcoma Diagnosis and Treatment 3
- Prostate Cancer Treatment and Research 3
- Ferroptosis and cancer prognosis 2
- Co-authors
- Antoîne Italiano (15 shared papers)Marina Pulido (5 shared papers)Alban Bessede (4 shared papers)Sophie Cousin (6 shared papers)Sophie Piperno‐Neumann (3 shared papers)Emmanuelle Bompas (4 shared papers)Nicolas Penel (4 shared papers)Jean‐Yves Blay (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (4 papers)Cancer Research (3 papers)Journal of Geriatric Oncology (2 papers)Future Oncology (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thomas Grellety
38 papers receiving 633 citations
Thomas Grellety's Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 343
- Gastroenterology 42
- Pulmonary and Respiratory Medicine 243
- Biological Psychiatry 18
- Immunology 134
Countries citing papers authored by Thomas Grellety
This map shows the geographic impact of Thomas Grellety's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Grellety with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Grellety more than expected).
Fields of papers citing papers by Thomas Grellety
This network shows the impact of papers produced by Thomas Grellety. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Grellety. The network helps show where Thomas Grellety may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Grellety, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas Hit paper breakdown → | 2017 | 303 |
| 2 | 2019 | 42 | |
| 3 | 2016 | 28 | |
| 4 | 2015 | 26 | |
| 5 | 2025 | 24 | |
| 6 | 2018 | 19 | |
| 7 | 2024 | 17 | |
| 8 | 2019 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2014 | 15 | |
| 11 | 2019 | 13 | |
| 12 | 2015 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2013 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2017 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2017 | 6 | |
| 19 | 2018 | 6 | |
| 20 | 2018 | 5 |
About Thomas Grellety
Thomas Grellety is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 43 papers that have together received 637 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Economic and Financial Impacts of Cancer (3 papers), Prostate Cancer Treatment and Research (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Oncology (343 citations), Gastroenterology (42 citations), Pulmonary and Respiratory Medicine (243 citations), Biological Psychiatry (18 citations) and Immunology (134 citations). Thomas Grellety has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Antoîne Italiano, Marina Pulido, Alban Bessede, Sophie Cousin, Sophie Piperno‐Neumann, Emmanuelle Bompas, Nicolas Penel, Jean‐Yves Blay, Axel Le Cesne and Maud Toulmonde. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Geriatric Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.